1. Home
  2. NTRA vs NOK Comparison

NTRA vs NOK Comparison

Compare NTRA & NOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$231.21

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Logo Nokia Corporation Sponsored

NOK

Nokia Corporation Sponsored

HOLD

Current Price

$6.43

Market Cap

36.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
NOK
Founded
2003
1865
Country
United States
Finland
Employees
N/A
N/A
Industry
Medical Specialities
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
32.9B
36.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
NOK
Price
$231.21
$6.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
2
Target Price
$249.53
$8.00
AVG Volume (30 Days)
1.1M
36.5M
Earning Date
02-26-2026
01-29-2026
Dividend Yield
N/A
1.67%
EPS Growth
N/A
N/A
EPS
N/A
0.13
Revenue
$2,116,676,000.00
$23,352,119,300.00
Revenue This Year
$33.77
$6.58
Revenue Next Year
$16.92
$3.98
P/E Ratio
N/A
$46.99
Revenue Growth
38.17
3.48
52 Week Low
$125.38
$4.00
52 Week High
$256.36
$8.19

Technical Indicators

Market Signals
Indicator
NTRA
NOK
Relative Strength Index (RSI) 44.72 46.97
Support Level $229.14 $6.06
Resistance Level $250.00 $7.09
Average True Range (ATR) 8.27 0.19
MACD -1.38 -0.02
Stochastic Oscillator 21.29 35.92

Price Performance

Historical Comparison
NTRA
NOK

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About NOK Nokia Corporation Sponsored

Nokia provides telecom equipment and services that are used to build wireless and fixed-line networks. It operates in four segments. The mobile networks segment sells equipment and services to telecom carriers to power public wireless networks. Network infrastructure focuses on fixed-line networks, including switching and routing equipment, optical components, and devices used in fiber-to-the-premises networks. The cloud and network services segment develops software used to operate the core of carrier wireless networks and build private networks for enterprises. Nokia also has a sizable research and patent business, where it licenses technology used by handset providers, consumer electronics firms, and other firms making electronic and Internet of Things products.

Share on Social Networks: